GC019F / AstraZeneca, Gracell  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GC019F / AstraZeneca
ChiCTR2100046670: An Early Exploratory Study of GC019F Injection in CD19 Positive Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Recruiting
N/A
12
 
GC019F
The First Affiliated Hospital of Zhengzhou University; The First Affiliated Hospital of Zhengzhou University, Gracell Biotechnologies
Acute B cell lymphoblastic leukemia
 
 

Download Options